CLNN

Clene (CLNN)

About Clene (CLNN)

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Details

Daily high

$6.69

Daily low

$6.01

Price at open

$6.04

52 Week High

$13.50

52 Week Low

$2.28

Market cap

72.0M

Dividend yield

0.00%

Volume

49,826

Avg. volume

101,317

P/E ratio

-2.35

Clene News